Clinical Trial Update: Intraoral 30% Glucose Effect In Newborns [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intraoral 30% glucose in newborns has completed, investigating effects in epilepsy and hydrocephaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Hydrocephaly

Drugs mentioned

• Glucose 30% intraoral solution (D-glucose)

Snippet

Sponsor: Baskent University | Conditions: Epilepsy, Hydrocephaly | Phase 3 | Status: COMPLETED